Menarini Silicon Biosystems, a pioneer of cell-based liquid biopsy technology, announced today the publication in Clinical ...

Findings from a study on the utility of ultrasensitive circulating tumor DNA (ctDNA) as a predictive biomarker for patients ...

Singlera Genomics, a company focused on the development and application of novel DNA methylation technologies to genetic ...

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It ...

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunes ...

The study does not suggest that chocolate is a shortcut to youth. It focuses on a nuanced discussion about how specific ...

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 22, 2025 /PRNewswire/ -- Menarini Silicon Biosystems, a pioneer of cell-based liquid biopsy technology, ann ...

This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...

In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...

AI maps fleeting DNA quadruplexes, revealing paired structures that control genes in healthy cells and cancer.

By moving around, some cancer cells force attacking immune cells to just nibble at the edges rather than engulf them ...